7Baggers

National HealthCare Corporation
(NYSE MKT:NHC) 

NHC stock logo

National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, home health care programs, and a behavioral health hospital. Its skilled nursing facilities offer licensed therapy services, nutrition se...

Founded: 1971
Full Time Employees: 14,881
Sector: Healthcare
Industry: Medical Care Facilities

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2011-12-31 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2007-06-30 2007-03-31 2006-12-31 2005-12-31 
                                                         
      revenues:
                                                         
      net patient revenues
    369,805,000 373,686,000 370,989,000 363,349,000 361,607,000 357,344,000 328,674,000 279,918,000 285,823,000 282,997,000 277,005,000 269,605,000 258,007,000 252,424,000 260,247,000 260,077,000 256,337,000 256,894,000 254,817,000 236,976,000 216,855,000 234,646,000 227,383,000 225,671,000 244,095,000 241,407,000 235,090,000 235,264,000 236,111,000 235,601,000 234,827,000 230,654,000 231,692,000  230,048,000 227,847,000 227,959,000       177,553,000 121,538,250 165,344,000 162,848,000 157,961,000  134,031 133,480   
      other revenues
    12,016,000 12,827,000 11,672,000 11,561,000 12,090,000 12,006,000 11,524,000 11,295,000 11,353,000 17,917,000 11,480,000 12,977,000 11,556,000 11,612,000 10,596,000 10,962,000 12,026,000 11,484,000 11,491,000 11,056,000 11,369,000 14,454,000 11,111,000 11,323,000 12,029,000 12,473,000 11,977,000 11,887,000 12,174,000 13,319,000 11,499,000 11,488,000 11,269,000  11,937,000 11,610,000 11,284,000       15,395,000 9,695,750 11,920,000 12,787,000 14,076,000  15,915 13,024   
      net operating revenues
    381,821,000    373,697,000    297,176,000                256,124,000 253,880,000 247,067,000 247,151,000 248,285,000 248,920,000 246,326,000 242,142,000 242,961,000  241,985,000 239,457,000                  
      cost and expenses:
                                                         
      salaries, wages, and benefits
    235,074,000 171,960,000 233,176,000 226,534,000 228,130,000 144,152,250 213,395,000 180,076,000 183,138,000 131,445,500 182,664,000 175,294,000 167,824,000 129,707,000 173,198,000 174,936,000 170,694,000 115,309,750 159,305,000 156,804,000 145,130,000 113,986,750 151,564,000 156,914,000                              
      other operating
    91,237,000 96,198,000 96,604,000 91,943,000 92,457,000 83,298,000 82,509,000 78,154,000 77,429,000 70,970,000 72,490,000 73,234,000 71,489,000 71,093,000 72,883,000 71,311,000 74,085,000 76,910,000 84,039,000 72,043,000 70,153,000 73,429,000 70,887,000 70,861,000 71,668,000 64,682,000 66,730,000 67,598,000 69,432,000 61,770,000 64,507,000 62,589,000 65,172,000  64,039,000 62,856,000 63,883,000       41,389,000 36,664,250 49,296,000 48,358,000 49,003,000  40,933 41,828   
      facility rent
    11,643,000 12,189,000 11,345,000 11,328,000 11,365,000 11,378,000 10,886,000 10,570,000 10,348,000 11,438,000 10,094,000 9,901,000 10,092,000 10,207,000 10,294,000 10,411,000 10,065,000 10,381,000 10,204,000 10,170,000 10,063,000 9,522,000 10,320,000 10,320,000 10,332,000 9,916,000 10,167,000 10,197,000 10,238,000 10,232,000 10,190,000 10,272,000 10,229,000  10,106,000 10,079,000 10,088,000                 
      depreciation and amortization
    11,614,000 11,769,000 11,158,000 11,015,000 10,978,000 11,442,000 10,619,000 9,338,000 10,586,000 11,768,000 10,135,000 10,083,000 10,048,000 10,478,000 10,253,000 10,001,000 9,757,000 10,151,000 10,229,000 10,131,000 10,161,000 10,487,000 10,548,000 10,545,000 10,438,000 10,904,000 10,663,000 10,335,000 10,517,000 10,718,000 10,437,000 10,397,000 10,342,000  10,833,000 10,481,000 10,295,000       6,962,000 4,972,500 6,800,000 6,663,000 6,427,000  3,828 3,756   
      total costs and expenses
    349,568,000 353,396,000 352,283,000 340,820,000 342,930,000 342,786,000 319,151,000 278,138,000 281,547,000 280,794,000 275,460,000 268,605,000 259,551,000 255,503,000 266,765,000 266,808,000 264,766,000 274,288,000 263,975,000 249,363,000 235,751,000 247,046,000 243,604,000 249,093,000 240,319,000 237,383,000 240,499,000 236,962,000 232,501,000 231,726,000 235,492,000 229,977,000 227,078,000  232,200,000 227,319,000              130,885 135,557   
      income from operations
    32,253,000 33,117,000 30,378,000 34,090,000 30,767,000 26,564,000 21,047,000 22,520,000 15,629,000 20,120,000 13,025,000 13,977,000 10,012,000 9,050,000 4,078,000 4,551,000 14,217,000 9,146,000 12,762,000 13,795,000 15,222,000 12,779,000 7,022,000 12,549,000 15,805,000 16,497,000 6,568,000 10,189,000 15,784,000 17,194,000 10,834,000 12,165,000 15,883,000                     
      yoy
    4.83% 24.67% 44.33% 51.38% 96.86% 32.03% 61.59% 61.12% 56.10% 122.32% 219.40% 207.12% -29.58% -1.05% -68.05% -67.01% -6.60% -28.43% 81.74% 9.93% -3.69% -22.54% 6.91% 23.16% 0.13% -4.05% -39.38% -16.24% -0.62%                         
      qoq
    -2.61% 9.02% -10.89% 10.80% 15.82% 26.21% -6.54% 44.09% -22.32% 54.47% -6.81% 39.60% 10.63% 121.92% -10.39% -67.99% 55.45% -28.33% -7.49% -9.37% 19.12% 81.99% -44.04% -20.60% -4.19% 151.17% -35.54% -35.45% -8.20% 58.70% -10.94% -23.41%                      
      other income:
                                                         
      non–operating income
    3,757,000 3,467,750 4,660,000 5,132,000 4,079,000 3,716,250 4,224,000 4,956,000 5,685,000 3,029,000 4,097,000 3,696,000 4,323,000 2,112,750 2,731,000 2,521,000 3,199,000 3,811,250 3,399,000 5,586,000 6,260,000 5,144,500 6,478,000 5,954,000 8,146,000 5,234,000 6,663,000 8,272,000 6,001,000 2,764,000 8,467,000 5,654,000 -3,065,000  6,090,000 5,189,000 4,768,000                 
      interest expense
    -269,000 -816,000 -1,456,000 -1,993,000 -2,106,000                                                 
      unrealized gains on marketable equity securities
    9,074,000 -4,404,000 20,827,000 -5,061,000 10,982,000 -25,332,000 32,767,000 9,124,000 14,399,000 12,001,000 -3,093,000 4,650,000 1,386,000   -3,549,000 3,126,000   -6,489,000 7,059,000 16,614,000 -241,000 20,053,000 -60,392,000 -3,866,000 9,312,000 -54,000 6,838,000 721,000 3,486,000 12,448,000                      
      income before income taxes
    44,815,000 32,133,000 54,409,000 32,168,000 43,722,000 6,057,000 58,038,000 36,600,000 35,713,000 36,665,000 14,029,000 22,323,000 15,721,000 7,413,000 -4,247,000 3,523,000 20,542,000 21,039,000 -7,636,000 108,094,000 28,541,000 37,049,000 13,259,000 38,556,000 -36,441,000 18,442,000 22,543,000 18,407,000 28,623,000 24,529,000 22,787,000 30,267,000 -2,699,000  15,875,000 17,327,000 20,632,000       30,442,000 -56,004,033 19,694,000 19,577,000 16,814,000  19,061 10,947   
      income tax provision
    -8,712,000 -6,939,000 -13,400,000 -8,055,000 -11,432,000 -28,000 -15,338,000 -9,494,000 -9,462,000   -6,406,000 -4,436,000   -1,362,000 -5,193,000   -2,764,000  -9,633,000 -391,000 -10,034,000  -4,755,000 -3,167,000 -4,725,000 -7,392,000 -6,393,000 -1,700,000 -7,892,000 -200,000  -4,691,000 -6,758,000 -7,999,000       -11,718,000 18,773,272 -4,611,000 -7,727,000 -6,407,000  -7,169 -3,907   
      net income
    36,103,000 25,194,000 41,009,000 24,113,000 32,290,000 6,029,000 42,700,000 27,106,000 26,251,000 27,965,000 10,121,000 15,917,000 11,285,000 5,574,000 -3,107,000 2,161,000 15,349,000 15,995,000 -3,546,000 105,330,000 21,308,000 27,416,000 12,868,000 28,522,000 -26,816,000 13,687,000 19,376,000 13,682,000 21,231,000 18,136,000 21,087,000 22,375,000 -2,899,000  11,184,000 10,569,000 12,633,000       18,724,000 -37,287,305 15,083,000 11,850,000 10,407,000  11,892 7,040   
      yoy
    11.81% 317.88% -3.96% -11.04% 23.00% -78.44% 321.90% 70.30% 132.62% 401.70% -425.75% 636.56% -26.48% -65.15% -12.38% -97.95% -27.97% -41.66% -127.56% 269.29% -179.46% 100.31% -33.59% 108.46% -226.31% -24.53% -8.11% -38.85% -832.36%  88.55% 111.70% -122.95%           79.92%  126733.17% 168223.86%       
      qoq
    43.30% -38.56% 70.07% -25.32% 435.58% -85.88% 57.53% 3.26% -6.13% 176.31% -36.41% 41.05% 102.46% -279.40% -243.78% -85.92% -4.04% -551.07% -103.37% 394.32% -22.28% 113.06% -54.88% -206.36% -295.92% -29.36% 41.62% -35.56% 17.07% -13.99% -5.76% -871.82%   5.82% -16.34%        -150.22% -347.21% 27.28% 13.87%   68.92%    
      net income attributable to noncontrolling interest
    -246,000   -391,000 -85,000            -31,000   -447,000 -41,000                                 
      net income attributable to national healthcare corporation
    35,857,000 24,849,000 39,239,000 23,722,000 32,205,000 6,081,000 42,789,000 26,844,000 26,213,000 28,406,000 10,388,000 16,281,000 11,723,000 6,353,000 -2,429,000 3,203,000 15,318,000 15,788,000 -3,348,000 104,883,000 21,267,000 27,550,000 12,849,000 28,324,000 -26,852,000 13,770,000 19,461,000 13,711,000 21,269,000 10,203,000 21,142,000 22,461,000 -2,791,000  11,352,000 10,655,000 12,728,000                 
      earnings per share attributable to national healthcare corporation stockholders:
                                                         
      basic
    2.31 1.61 2.53 1.53 2.09 0.39 2.78 1.74 1.71 1.85 0.68 1.06 0.76 0.42 -0.16 0.21 0.99 1.03 -0.22 6.83 1.39 1.8 0.84 1.85 -1.76 0.9 1.27 0.9 1.39 1.19 1.39 1.48 -0.18  0.75 0.7 0.84             0.95 0.56   
      diluted
    2.27 1.57 2.5 1.52 2.07 0.38 2.73 1.73 1.69 1.84 0.68 1.06 0.76 0.41 -0.16 0.21 0.99 1.02 -0.22 6.8 1.38 1.79 0.84 1.84 -1.76 0.89 1.27 0.89 1.39 1.19 1.39 1.47 -0.18  0.75 0.7 0.84             0.92 0.54   
      weighted-average common shares outstanding:
                                                         
      basic
    15,541,634 15,472,185 15,484,464 15,462,135 15,438,306 15,393,782 15,411,680 15,391,535 15,350,240 15,310,142 15,299,913 15,297,435 15,337,423 15,410,222 15,445,569 15,452,402 15,416,836 15,347,129 15,364,043 15,349,162 15,327,520 15,306,174 15,310,754 15,307,105 15,294,777 15,270,154  15,269,637 15,256,189 15,224,886 15,225,654 15,221,262 15,216,635  15,195,394 15,189,818 15,173,491       13,680,135,000  13,649,174,000 13,746,482,000 13,721,570,000  12,538,104 12,526,231   
      diluted
    15,770,507 15,646,338 15,664,530 15,599,638 15,575,752 15,598,528 15,667,321 15,555,612 15,505,096 15,377,343 15,324,511 15,322,344 15,356,335 15,447,211 15,445,569 15,487,123 15,463,855 15,416,716 15,364,043 15,419,012 15,390,076 15,369,523 15,371,311 15,372,430 15,294,777 15,360,046  15,352,702 15,324,125 15,236,826 15,242,086 15,228,305 15,216,635  15,220,567 15,220,448 15,212,133       16,327,236,000  13,650,916,000 13,747,450,000 13,725,201,000  12,994,966 12,992,219   
      government stimulus income
         2,361,250  9,445,000      517,000  320,000 10,620,000 15,056,000 10,429,000 15,126,000 22,749,000 10,725,000 12,132,000 24,648,000                              
      net operating revenues and grant income
     282,817,000 382,661,000 374,910,000  369,350,000 340,198,000 300,658,000  300,914,000 288,485,000 282,582,000 269,563,000 264,553,000 270,843,000 271,359,000 278,983,000 283,434,000 276,737,000 263,158,000 250,973,000 259,825,000 250,626,000 261,642,000                              
      net loss attributable to noncontrolling interest
     -345,000 -1,770,000   52,000 89,000 -262,000 -38,000 441,000 267,000 364,000  779,000 678,000 1,042,000  -207,000 198,000   134,000 -19,000 -198,000  83,000 85,000 29,000 38,000 16,000 55,000 86,000 108,000                     
      dividends declared per common share
     0.64 0.64 0.64  0.61 0.61 0.61 0.59 0.59 0.59 0.59 0.57 0.57 0.57 0.57 0.55 0.55 0.52 0.52 0.52 0.52 0.52 0.52 0.52 0.52 0.52 0.52 0.5 0.5 0.5 0.5 0.48  0.48 0.48 0.45                 
      interest
         2,347,000 1,742,000  46,000 56,000 77,000 93,000 98,000 112,000 137,000 149,000 165,000 188,000 198,000 215,000 244,000 249,000 285,000 453,000 412,000 491,000 764,000 954,000 926,000 1,034,000 1,170,000 1,253,000 1,240,000  1,322,000 1,219,000 1,058,000       89,000 99,000 136,000 146,000 114,000  294 276   
      revenues and grant income:
                                                         
      income tax benefit
             -3,687,500 -3,908,000   -1,353,750 1,140,000   -1,476,750 4,090,000  -7,233,000    9,625,000                             
      net loss attributable to noncontrolling interest
                438,000                                         
      gain on acquisition of equity method investment
                                                         
      unrealized losses on marketable equity securities
                 -2,869,750 -11,056,000                                       
      gains on acquisitions of equity method investments
                     23,800,500  95,202,000                                  
      unrealized losses on marketable equity securities
                     -5,806,750 -23,797,000              -15,517,000                     
      other income/
                                                         
      salaries, wages and benefits
                            147,469,000 151,390,000 152,175,000 147,878,000 141,388,000 147,972,000 149,188,000 145,466,000 140,095,000  145,900,000 142,684,000 138,055,000       108,762,000 73,071,750 98,531,000 97,680,000 96,076,000  81,539 79,174   
      loss attributable to noncontrolling interest
                            -36,000          168,000 86,000                  
      earnings per share attributable to national healthcare corporation stockholders:
                                                         
      basic
    2.31 1.61 2.53 1.53 2.09 0.39 2.78 1.74 1.71 1.85 0.68 1.06 0.76 0.42 -0.16 0.21 0.99 1.03 -0.22 6.83 1.39 1.8 0.84 1.85 -1.76 0.9 1.27 0.9 1.39 1.19 1.39 1.48 -0.18  0.75 0.7 0.84             0.95 0.56   
      diluted
    2.27 1.57 2.5 1.52 2.07 0.38 2.73 1.73 1.69 1.84 0.68 1.06 0.76 0.41 -0.16 0.21 0.99 1.02 -0.22 6.8 1.38 1.79 0.84 1.84 -1.76 0.89 1.27 0.89 1.39 1.19 1.39 1.47 -0.18  0.75 0.7 0.84             0.92 0.54   
      basic
                             3,816,812.5 15,275,709                           
      diluted
                             3,837,577 15,373,617                           
      income before non–operating income
                                      9,785,000 12,138,000 15,864,000                 
      add: net loss attributable to noncontrolling interest
                                        -95,000                 
      costs and expenses:
                                                         
      rent
                                               9,865,000 6,144,750 8,231,000 8,170,000 8,178,000  10,486 10,523   
      income before non-operating income
                                               25,881,000 10,281,750 14,270,000 14,618,000 12,239,000      
      non-operating income
                                               4,561,000 -14,934,660 5,424,000 4,959,000 4,575,000      
      dividends to preferred stockholders
                                               -2,168,000 6,513,673 -2,169,000 -2,168,000 -2,168,000      
      net income available to common stockholders
                                               16,556,000 -30,790,978 12,914,000 9,682,000 8,239,000      
      earnings per common share:
                                                         
      basic
                                               1,210 -2,246.78 950 700 600      
      diluted
                                               1,150 -2,246.78 950 700 600      
      net revenues
                                                     149,946 146,504   
      recovery of notes receivable
                                                     -6,195    
      earnings per share:
                                                         
      basic
    2.31 1.61 2.53 1.53 2.09 0.39 2.78 1.74 1.71 1.85 0.68 1.06 0.76 0.42 -0.16 0.21 0.99 1.03 -0.22 6.83 1.39 1.8 0.84 1.85 -1.76 0.9 1.27 0.9 1.39 1.19 1.39 1.48 -0.18  0.75 0.7 0.84             0.95 0.56   
      diluted
    2.27 1.57 2.5 1.52 2.07 0.38 2.73 1.73 1.69 1.84 0.68 1.06 0.76 0.41 -0.16 0.21 0.99 1.02 -0.22 6.8 1.38 1.79 0.84 1.84 -1.76 0.89 1.27 0.89 1.39 1.19 1.39 1.47 -0.18  0.75 0.7 0.84             0.92 0.54   
      weighted-average shares outstanding:
                                                         
      basic
    15,541,634 15,472,185 15,484,464 15,462,135 15,438,306 15,393,782 15,411,680 15,391,535 15,350,240 15,310,142 15,299,913 15,297,435 15,337,423 15,410,222 15,445,569 15,452,402 15,416,836 15,347,129 15,364,043 15,349,162 15,327,520 15,306,174 15,310,754 15,307,105 15,294,777 15,270,154  15,269,637 15,256,189 15,224,886 15,225,654 15,221,262 15,216,635  15,195,394 15,189,818 15,173,491       13,680,135,000  13,649,174,000 13,746,482,000 13,721,570,000  12,538,104 12,526,231   
      diluted
    15,770,507 15,646,338 15,664,530 15,599,638 15,575,752 15,598,528 15,667,321 15,555,612 15,505,096 15,377,343 15,324,511 15,322,344 15,356,335 15,447,211 15,445,569 15,487,123 15,463,855 15,416,716 15,364,043 15,419,012 15,390,076 15,369,523 15,371,311 15,372,430 15,294,777 15,360,046  15,352,702 15,324,125 15,236,826 15,242,086 15,228,305 15,216,635  15,220,567 15,220,448 15,212,133       16,327,236,000  13,650,916,000 13,747,450,000 13,725,201,000  12,994,966 12,992,219   
                                                         
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-03-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-03-31 2005-12-31 
                                                                  
        assets
                                                                  
        current assets:
                                                                  
        cash and cash equivalents
      85,526,000 92,829,000 130,629,000 110,992,000 90,386,000 76,121,000 84,807,000 136,214,000 93,982,000 107,076,000 100,308,000 78,492,000 46,144,000 58,667,000 44,515,000 75,798,000 56,993,000 107,607,000 112,462,000 134,692,000 134,107,000 147,093,000 183,765,000 149,471,000 69,492,000 50,334,000 59,261,000 29,746,000 38,194,000 43,247,000 55,599,000 59,322,000 54,962,000 59,118,000 69,790,000                        57,246,000 60,870,000 
        restricted cash and cash equivalents, current portion
      19,605,000 18,118,000 19,664,000 18,155,000 24,589,000 19,568,000 29,032,000 28,183,000 26,010,000 17,725,000 18,865,000 23,330,000 27,485,000 15,121,000 25,838,000 13,939,000 17,187,000 10,407,000 12,506,000 14,093,000 20,257,000 9,673,000 10,623,000 19,561,000 12,947,000 8,944,000 7,114,000 34,436,000 14,785,000  10,209,000                              
        marketable equity securities
      172,826,000 162,972,000 166,754,000 146,636,000 152,785,000 140,064,000 164,754,000 133,317,000 123,040,000 111,117,000 102,137,000 103,812,000 100,825,000 100,786,000 107,655,000 117,917,000 118,048,000 113,108,000 105,893,000 128,666,000 135,246,000 128,590,000 111,873,000 112,114,000 92,061,000 152,453,000 156,319,000 147,007,000 147,061,000  139,502,000 136,016,000 123,568,000                            
        restricted marketable equity securities
      16,624,000 17,197,000 17,482,000 16,269,000 21,697,000 23,190,000 23,001,000 21,566,000 29,616,000 26,779,000 23,683,000 25,127,000 23,385,000 22,358,000 20,341,000 21,446,000 25,249,000 26,958,000 24,520,000 25,174,000 5,083,000 4,680,000                                       
        restricted marketable debt securities, current portion
      16,991,000 18,062,000 12,821,000 13,854,000 6,483,000 11,529,000 2,045,000 2,583,000 4,790,000 12,822,000 12,005,000 8,018,000 3,950,000 16,244,000 5,014,000 17,130,000 13,703,000 20,727,000 18,794,000 16,839,000 5,724,000 16,601,000 19,249,000 10,265,000 16,685,000 20,576,000 21,222,000  13,486,000  17,606,000                              
        accounts receivable
      137,742,000 139,002,000 132,448,000 142,061,000 141,741,000 135,325,000 128,782,000 109,387,000 125,664,000 108,545,000 102,603,000 101,260,000 103,134,000 99,986,000 99,003,000 100,415,000 101,748,000 96,124,000 99,019,000 97,811,000 94,292,000 89,670,000 84,595,000 85,849,000 100,411,000 92,975,000 92,040,000 97,448,000 100,619,000 97,274,000 87,263,000 82,230,000 85,006,000                            
        inventories
      9,150,000 7,795,000 7,844,000 7,892,000 8,079,000 9,039,000 7,840,000 6,632,000 6,763,000 7,386,000 7,373,000 6,995,000 6,946,000 7,088,000 7,298,000 7,363,000 8,586,000 8,582,000 8,696,000 7,939,000 8,117,000 8,781,000 7,188,000 7,200,000 7,904,000 7,441,000 7,774,000 7,317,000 6,953,000 7,470,000 7,590,000 7,306,000 7,266,000 7,153,000 7,113,000                         5,623,000 
        prepaid expenses and other assets
      7,112,000 5,845,000 5,877,000 7,368,000 8,939,000 9,060,000 4,887,000 8,788,000 6,750,000 8,855,000 7,555,000 10,560,000 8,212,000 10,244,000 10,306,000 14,657,000 11,519,000 7,362,000 5,450,000 6,160,000 3,496,000 2,977,000 3,682,000 4,345,000 5,397,000 4,075,000 3,674,000 4,192,000 4,598,000 3,863,000 3,163,000 3,428,000 3,478,000 2,864,000 2,582,000                        1,973,000 1,206,000 
        total current assets
      465,576,000 461,820,000 493,519,000 463,227,000 455,204,000 424,408,000 445,726,000 447,871,000 417,586,000 406,235,000 382,578,000 368,734,000 337,903,000 353,932,000 344,529,000 394,781,000 384,020,000 426,638,000 424,829,000 465,907,000 464,618,000 456,755,000 422,228,000 390,204,000 306,682,000 341,053,000 351,190,000 321,577,000 327,113,000 322,009,000 324,473,000 317,494,000 305,160,000 329,311,000 336,096,000                        298,620,000 260,579,000 
        property and equipment:
                                                                  
        property and equipment, at cost
      1,318,245,000 1,308,891,000 1,305,640,000 1,295,976,000 1,287,825,000 1,281,736,000 1,283,184,000 1,073,356,000 1,065,543,000 1,101,681,000 1,102,467,000 1,096,659,000 1,087,834,000 1,081,219,000 1,076,116,000 1,076,974,000 1,073,293,000 1,064,337,000 1,062,620,000 1,050,009,000 1,034,747,000 1,030,426,000 1,041,832,000 1,038,586,000 1,032,795,000 1,017,204,000 1,010,629,000 1,009,842,000 987,763,000 979,088,000 977,373,000 974,049,000 965,774,000 958,748,000 954,739,000                        261,780,000 225,928,000 
        accumulated depreciation and amortization
      -646,422,000 -635,094,000 -630,471,000 -619,357,000 -608,377,000 -597,447,000 -596,759,000 -586,163,000 -576,845,000 -608,352,000 -604,201,000 -594,769,000 -584,710,000 -574,687,000 -564,743,000 -561,203,000 -553,092,000 -543,341,000 -540,601,000 -530,392,000 -520,263,000 -510,108,000 -511,216,000 -502,622,000 -492,175,000 -481,774,000 -471,025,000 -465,256,000 -454,959,000 -444,438,000 -436,437,000 -430,014,000 -419,697,000 -409,429,000 -402,396,000                         -118,794,000 
        net property and equipment
      671,823,000 673,797,000 675,169,000 676,619,000 679,448,000 684,289,000 686,425,000 487,193,000 488,698,000 493,329,000 498,266,000 501,890,000 503,124,000 506,532,000 511,373,000 515,771,000 520,201,000 520,996,000 522,019,000 519,617,000 514,484,000 520,318,000 530,616,000 535,964,000 540,620,000 535,430,000 539,604,000 544,586,000 532,804,000 534,650,000 540,936,000 544,035,000 546,077,000 549,319,000 552,343,000                         107,134,000 
        other assets:
                                                                  
        restricted cash and cash equivalents, less current portion
      1,197,000 1,240,000 1,241,000 1,215,000 1,186,000 1,233,000 1,235,000 1,208,000 1,140,000 1,167,000 1,082,000 1,083,000 1,047,000 1,077,000 1,847,000 1,831,000 1,736,000 1,729,000 1,799,000 1,802,000 1,727,000 1,736,000 1,730,000 1,747,000 1,741,000 1,732,000 1,707,000 1,724,000 1,720,000  1,925,000                              
        restricted marketable debt securities, less current portion
      105,841,000 105,231,000 110,091,000 119,847,000 113,684,000 108,275,000 121,866,000 116,724,000 119,042,000 109,478,000 106,857,000 110,125,000 117,450,000 103,267,000 118,858,000 112,725,000 118,098,000 116,063,000 118,737,000 115,856,000 133,959,000 125,472,000 122,791,000 139,323,000 131,126,000 126,830,000     150,428,000                              
        deposits and other assets
      7,546,000 7,478,000 9,438,000 10,599,000 8,513,000 8,837,000 10,084,000 10,364,000 13,738,000 14,786,000 13,472,000 13,130,000 13,103,000 12,728,000 13,039,000 4,140,000 4,956,000 4,499,000 4,798,000 4,681,000 4,661,000 4,580,000 5,503,000 5,767,000 5,897,000 5,124,000 5,636,000 5,903,000 5,895,000 5,602,000 5,807,000 5,849,000 4,884,000 4,867,000 6,228,000                          
        operating lease right-of-use assets
      39,787,000  55,821,000 63,663,000 70,147,000  85,926,000 80,819,000 87,356,000  100,788,000 107,043,000 113,799,000  126,499,000 143,841,000 150,191,000  162,550,000 168,572,000 172,764,000  185,003,000 191,029,000 196,960,000  208,785,000 214,367,000 220,134,000                                
        goodwill
      170,478,000 170,478,000 170,478,000 170,478,000 170,478,000 170,478,000 169,690,000 168,295,000 168,295,000 168,295,000 168,295,000 168,295,000 168,295,000 168,295,000 168,295,000 168,295,000 168,295,000 168,295,000 168,295,000 168,295,000 21,341,000 21,341,000 21,341,000 21,341,000 21,341,000 20,995,000 20,995,000 20,995,000 20,995,000 20,995,000 20,995,000 17,600,000 17,600,000 17,600,000 17,600,000                        3,033,000 3,033,000 
        intangible assets
      19,864,000 19,864,000 19,864,000 19,864,000 19,864,000 19,864,000 19,805,000 7,038,000 7,038,000 7,038,000 7,038,000 7,038,000 7,038,000 7,038,000 7,038,000 7,038,000 7,038,000 7,038,000 7,038,000 7,038,000                                         
        investments in unconsolidated companies
      41,982,000 38,733,000 36,521,000 36,708,000 30,297,000 27,878,000 21,950,000 20,187,000 16,747,000 16,267,000 3,531,000 3,346,000 3,594,000 2,060,000 2,081,000 2,047,000 2,476,000 2,022,000 2,231,000 1,867,000 37,796,000 40,782,000 36,888,000 36,897,000 38,772,000 39,191,000 36,987,000 35,675,000 34,777,000                                
        total other assets
      386,695,000 390,802,000 403,454,000 422,374,000 414,169,000 415,732,000 430,556,000 404,635,000 413,356,000 411,232,000 401,063,000 410,060,000 424,326,000 414,986,000 439,657,000 439,917,000 452,790,000 455,762,000 468,950,000 471,845,000 376,210,000 385,059,000 385,935,000 409,070,000 409,005,000 410,165,000 416,437,000 448,452,000 452,380,000 224,289,000 219,259,000 209,220,000 207,984,000 217,896,000 222,398,000                        61,452,000 42,912,000 
        total assets
      1,524,094,000 1,526,419,000 1,572,142,000 1,562,220,000 1,548,821,000 1,524,429,000 1,562,707,000 1,339,699,000 1,319,640,000 1,310,796,000 1,281,907,000 1,280,684,000 1,265,353,000 1,275,450,000 1,295,559,000 1,350,469,000 1,357,011,000 1,403,396,000 1,415,798,000 1,457,369,000 1,355,312,000 1,362,132,000 1,338,779,000 1,335,238,000 1,256,307,000 1,286,648,000 1,307,231,000 1,314,615,000 1,312,297,000 1,080,948,000 1,084,668,000 1,070,749,000 1,059,221,000 1,096,526,000 1,110,837,000     922,447,000 922,447,000 920,181,000 920,181,000                487,297,000 410,625,000 
        liabilities and stockholders’ equity
                                                                  
        current liabilities:
                                                                  
        trade accounts payable
      21,371,000 22,767,000 22,567,000 21,279,000 21,646,000 25,493,000 22,724,000 21,782,000 20,697,000 19,194,000 16,471,000 14,520,000 12,940,000 16,958,000 19,443,000 26,140,000 25,842,000 22,488,000 32,900,000 22,246,000 16,113,000 21,112,000 19,890,000 18,442,000 18,275,000 18,903,000 18,693,000 15,737,000 19,318,000 19,759,000 19,611,000 16,166,000 16,715,000 15,978,000 14,736,000                        11,040,000 10,431,000 
        operating lease liabilities, current portion
      26,018,000 33,611,000 33,198,000 32,729,000 32,109,000 31,841,000 31,366,000 30,233,000 29,733,000 29,352,000 29,222,000 29,112,000 29,065,000 29,075,000 28,611,000 28,358,000 28,005,000 27,574,000 27,289,000 26,873,000 25,759,000 25,451,000 25,146,000 24,850,000 24,557,000 24,243,000 23,988,000 23,625,000 23,353,000                                
        accrued payroll
      109,575,000 103,917,000 109,991,000 111,644,000 96,260,000 92,719,000 89,757,000 82,237,000 64,156,000 84,110,000 69,719,000 67,329,000 56,710,000 72,510,000 77,342,000 85,661,000 73,877,000 106,698,000 85,926,000 93,264,000 64,406,000 86,183,000 60,690,000 61,210,000 48,892,000 69,826,000 59,497,000 56,691,000 45,888,000 67,618,000 58,487,000 55,688,000 44,483,000 67,102,000 55,586,000                        38,218,000 41,929,000 
        amounts due to third party payors
      14,062,000 13,739,000 15,060,000 15,160,000 13,897,000 15,351,000 18,815,000 18,218,000 19,988,000 18,369,000 15,588,000 15,659,000 16,679,000 16,631,000 15,496,000 18,019,000 17,319,000 17,595,000 17,046,000 16,931,000 15,574,000 16,454,000 15,642,000 17,824,000 15,607,000 15,108,000 15,911,000 16,799,000 16,293,000 16,108,000 17,596,000 17,218,000 17,155,000 17,389,000 20,649,000                         4,815,000 
        accrued risk reserves, current portion
      36,595,000 36,180,000 32,486,000 32,008,000 31,073,000 31,096,000 31,076,000 30,766,000 30,800,000 30,549,000 30,870,000 31,348,000 31,435,000 31,365,000 30,852,000 31,069,000 30,890,000 31,134,000 31,300,000 30,932,000 31,065,000 30,953,000 29,873,000 29,827,000 29,632,000 29,520,000 28,335,000 28,496,000 28,271,000 28,643,000 27,815,000 27,693,000 27,931,000 27,409,000 25,410,000                          
        other current liabilities
      33,215,000 25,977,000 51,627,000 38,506,000 27,296,000 21,377,000 37,289,000 24,291,000 24,302,000 22,991,000 31,650,000 27,401,000 23,021,000 17,615,000 24,073,000 20,350,000 21,760,000 20,059,000 23,550,000 19,639,000 25,674,000 21,344,000 23,431,000 27,425,000 18,811,000 15,029,000 22,594,000 18,330,000 22,407,000 14,249,000 16,561,000 14,808,000 14,312,000 16,194,000 20,293,000                        13,452,000 11,295,000 
        dividends payable
      9,989,000 9,941,000 9,930,000 9,919,000 9,444,000 9,420,000 9,419,000 9,408,000 9,086,000 9,051,000 9,040,000 9,039,000 8,733,000 8,748,000 8,774,000 8,828,000 8,509,000 8,493,000 8,020,000 8,020,000 8,003,000 7,987,000 7,987,000 7,986,000 7,980,000 7,968,000 7,966,000 7,966,000 7,652,000 7,623,000 7,613,000 7,612,000 7,305,000 7,297,000 7,294,000                        2,255,000 1,837,000 
        long-term debt due within one year
       7,500,000   7,500,000 7,500,000 7,500,000                                                      
        total current liabilities
      250,825,000 253,632,000 282,359,000 268,745,000 239,225,000 234,797,000 247,946,000 216,935,000 206,429,000 214,476,000 204,694,000 197,798,000 183,210,000 197,887,000 210,156,000 224,365,000 216,487,000 263,201,000 257,670,000 273,012,000 265,846,000 281,228,000 259,673,000 262,142,000 217,982,000 194,763,000 181,088,000 171,687,000 169,962,000 157,924,000 151,548,000 142,993,000 131,652,000 155,065,000 147,609,000                        167,042,000 147,191,000 
        long-term debt
       32,500,000 65,625,000 102,500,000 126,500,000 129,500,000 139,500,000                               120,000,000 10,000,000     10,000,000 10,000,000  10,000,000 10,000,000             
        operating lease liabilities, less current portion
      13,296,000 13,461,000 21,746,000 29,884,000 36,812,000 45,925,000 53,079,000 49,032,000 56,004,000 63,175,000 70,200,000 76,878,000 83,988,000 91,016,000 97,888,000 115,483,000 122,186,000 128,542,000 135,261,000 141,699,000 147,005,000 153,604,000 159,857,000 166,179,000 172,403,000 178,666,000 184,797,000 190,742,000 196,781,000                                
        accrued risk reserves, less current portion
      89,905,000 85,415,000 81,546,000 76,974,000 77,124,000 72,520,000 79,128,000 78,488,000 77,437,000 72,710,000 77,255,000 74,872,000 74,191,000 71,104,000 72,858,000 71,594,000 70,523,000 66,914,000 72,524,000 70,918,000 70,416,000 68,584,000 76,080,000 75,181,000 71,130,000 66,491,000 69,944,000 68,795,000 70,271,000 67,381,000 67,972,000 67,115,000 68,315,000 65,866,000 70,103,000  65,264,000 71,439,000 79,393,000                      
        refundable entrance fees
      5,992,000 6,178,000 6,127,000 6,107,000 6,234,000 6,063,000 6,063,000 5,856,000 5,708,000 6,376,000 5,949,000 5,728,000 6,036,000 6,207,000 6,171,000 6,304,000 6,097,000 7,011,000 6,868,000 7,461,000 7,334,000 7,462,000 7,462,000 7,643,000 7,455,000 7,455,000 7,394,000 7,975,000 8,078,000 8,078,000 8,668,000 8,668,000 8,668,000 8,827,000 8,827,000  9,924,000 9,865,000 10,219,000 -10,680,000                     
        deferred income taxes
      45,250,000 42,687,000 38,769,000 34,639,000 37,110,000 35,550,000 30,842,000 23,492,000 19,639,000 17,200,000 9,847,000 12,227,000 11,519,000 10,909,000 9,750,000 9,278,000 8,078,000 6,852,000 8,037,000 13,463,000 15,157,000 14,079,000 14,185,000 12,953,000 8,469,000 24,012,000 26,193,000 21,145,000 20,830,000 18,550,000 18,648,000 15,240,000 12,580,000 18,376,000 26,027,000  22,072,000 9,096,000  10,564,000 10,564,000                  30,757,000 16,690,000 
        other noncurrent liabilities
      22,212,000 18,031,000 17,743,000 17,988,000 17,834,000 16,911,000 19,353,000 18,051,000 27,909,000 26,379,000 26,622,000 26,823,000 26,507,000 19,953,000 15,274,000 17,445,000 17,957,000 16,571,000 26,503,000 29,336,000 29,973,000 28,375,000 32,674,000 29,068,000 14,590,000 16,058,000 13,765,000 15,395,000 15,306,000 15,204,000 14,703,000 16,335,000 16,132,000 15,795,000 15,542,000  16,302,000 16,294,000 16,011,000     18,903,000 18,896,000 18,861,000 20,881,000 23,311,000 23,139,000 22,633,000 19,458,000 15,959,000 15,900,000 15,807,000     22,260,000 14,003,000 
        total liabilities
      427,480,000 451,904,000 513,915,000 536,837,000 540,839,000 541,266,000 575,911,000 391,854,000 393,126,000 400,316,000 394,567,000 394,326,000 385,451,000 397,936,000 414,231,000 447,859,000 445,955,000 494,936,000 513,908,000 544,117,000 545,124,000 563,872,000 561,602,000 565,951,000 512,952,000 507,579,000 535,200,000 554,368,000 561,582,000 346,491,000 363,450,000 363,979,000 367,584,000 393,094,000 419,348,000                          
        equity:
                                                                  
        common stock, .01 par value...
      156,000 155,000 154,000 154,000 154,000 154,000 154,000 154,000 154,000 153,000 153,000 153,000 153,000 153,000 153,000 154,000 154,000 154,000 154,000 154,000 154,000 153,000 153,000 153,000 153,000 153,000 153,000 153,000 153,000 153,000 152,000 152,000 152,000 152,000 152,000                         123,000 
        capital in excess of par value
      233,639,000 236,412,000 235,878,000 234,868,000 233,113,000 232,530,000 230,635,000 229,410,000 226,909,000 227,604,000 226,888,000 225,926,000 225,148,000 226,991,000 228,522,000 234,482,000 232,733,000 232,167,000 230,974,000 230,248,000 227,487,000 226,943,000 225,616,000 224,972,000 223,600,000 222,787,000 221,394,000 221,054,000 219,566,000 219,435,000 217,657,000 217,296,000 216,287,000 215,659,000 214,347,000                        94,435,000 84,431,000 
        retained earnings
      858,852,000 832,984,000 818,076,000 788,767,000 774,954,000 752,193,000 755,532,000 722,162,000 704,726,000 687,599,000 668,244,000 666,896,000 659,654,000 656,664,000 659,059,000 670,262,000 675,887,000 669,078,000 661,783,000 673,151,000 576,288,000 563,024,000 543,460,000 538,599,000 518,261,000 553,093,000 547,292,000 535,797,000 530,052,000 516,435,000 505,906,000 492,377,000 477,528,000 419,423,000 405,250,000     283,517,000 283,517,000 283,517,000 283,517,000                 101,461,000 
        accumulated other comprehensive loss
      -1,698,000 -779,000 -1,129,000 -1,884,000 -3,326,000 -4,716,000 -2,853,000 -5,909,000 -7,041,000 -6,604,000 -10,114,000 -9,053,000 -7,853,000                -197,000                                
        total national healthcare corporation stockholders’ equity
      1,090,949,000 1,068,772,000 1,052,979,000 1,021,905,000 1,004,895,000 980,161,000 983,468,000 945,817,000 924,748,000 908,752,000 885,171,000 883,922,000 877,102,000 874,276,000 877,311,000 897,915,000 905,319,000 903,004,000 895,677,000 906,841,000 807,064,000 795,177,000 773,960,000 768,052,000 742,562,000 778,593,000 771,570,000 759,152,000 749,574,000 733,278,000 720,023,000 706,270,000 691,051,000 702,738,000 690,868,000                          
        noncontrolling interest
      5,665,000 5,743,000 5,248,000 3,478,000 3,087,000 3,002,000 3,328,000 2,028,000 1,766,000 1,728,000 2,169,000 2,436,000 2,800,000 3,238,000 4,017,000 4,695,000 5,737,000 5,456,000 6,213,000 6,411,000 3,124,000 3,083,000 3,217,000 1,235,000 793,000 476,000 461,000 1,095,000 1,141,000 1,179,000 1,195,000 500,000 586,000 694,000 621,000                          
        total equity
      1,096,614,000 1,074,515,000 1,058,227,000 1,025,383,000 1,007,982,000 983,163,000 986,796,000 947,845,000 926,514,000 910,480,000 887,340,000 886,358,000 879,902,000 877,514,000 881,328,000 902,610,000 911,056,000 908,460,000 901,890,000 913,252,000 810,188,000 798,260,000 777,177,000 769,287,000 743,355,000 779,069,000 772,031,000 760,247,000 750,715,000 734,457,000 721,218,000 706,770,000 691,637,000 703,432,000                           
        total liabilities and equity
      1,524,094,000 1,526,419,000 1,572,142,000 1,562,220,000 1,548,821,000 1,524,429,000 1,562,707,000 1,339,699,000 1,319,640,000 1,310,796,000 1,281,907,000 1,280,684,000 1,265,353,000 1,275,450,000 1,295,559,000 1,350,469,000 1,357,011,000 1,403,396,000 1,415,798,000 1,457,369,000 1,355,312,000 1,362,132,000 1,338,779,000 1,335,238,000 1,256,307,000 1,286,648,000 1,307,231,000 1,314,615,000 1,312,297,000 1,080,948,000 1,084,668,000 1,070,749,000 1,059,221,000 1,096,526,000                           
        operating lease – right-of-use assets
       47,778,000    79,167,000    94,201,000    120,521,000    156,116,000    179,055,000    202,909,000                                   
        liabilities and equity
                                                                  
        long-term debt, current portion
        7,500,000 7,500,000                                                         
        notes receivable
          505,000 512,000 578,000 713,000 487,000 503,000    302,000 2,000,000                                            189,000 189,000 
        marketable debt securities
             488,000 484,000 5,427,000 8,049,000 11,140,000 17,822,000 23,136,000 24,559,000 26,116,000 30,987,000 35,310,000 36,590,000 33,651,000 49,492,000 47,762,000                                       
        finance lease obligations, current portion
               860,000 2,134,000 3,390,000 4,627,000 4,985,000 4,911,000 4,838,000 4,766,000 4,695,000 4,626,000 4,557,000 4,489,000 4,423,000 4,357,000 4,292,000 4,228,000 4,166,000 4,104,000 4,043,000 6,780,000                                
        contract liabilities
              7,667,000      138,000 586,000 5,003,000 15,022,000 27,013,000 40,121,000 51,253,000 51,253,000 51,253,000 50,992,000                                     
        finance lease obligations, less current portion
                   860,000 2,134,000 3,390,000 4,627,000 5,845,000 7,045,000 8,228,000 9,393,000 10,540,000 11,671,000 12,785,000 13,882,000 14,963,000 16,028,000 17,077,000 18,110,000                                
        provider relief funds
                    516,000 516,000 516,000 9,443,000  10,429,000 23,510,000 16,068,000 21,404,000 19,294,000                                     
        accumulated other comprehensive income
                   -9,532,000 -10,423,000 -6,983,000 -3,455,000 1,605,000 2,766,000 3,288,000 3,135,000 5,057,000 4,731,000 4,328,000 548,000 2,560,000 2,731,000 2,148,000  -2,745,000 -3,692,000 -3,555,000 -2,916,000 67,504,000 71,119,000                          
        notes receivable, current portion
                       453,000 899,000 882,000 8,804,000 928,000 1,253,000 1,399,000 1,785,000 1,695,000 1,456,000 1,431,000 1,417,000 1,289,000 1,338,000 1,499,000 1,422,000 1,450,000 1,267,000                          
        notes receivable, less current portion
                        3,502,000 3,734,000 3,962,000 12,093,000 12,679,000 12,966,000 13,168,000 13,384,000 13,992,000 14,217,000 9,538,000 9,707,000 10,031,000 10,952,000 11,398,000 11,801,000 11,989,000                          
        current maturities of long-term debt
                              50,000,000 10,000,000                                   
        federal income tax receivable
                               2,560,000 2,330,000    2,203,000  1,527,000 5,465,000 5,913,000                          
        obligation to provide future services
                              2,035,000 2,035,000 2,172,000 2,172,000 2,172,000 2,172,000 2,887,000 2,887,000 2,887,000 2,887,000 3,236,000  3,236,000 3,440,000 3,927,000 -1,791,000                     
        deferred revenue
                              5,006,000 3,136,000 3,819,000 4,380,000 5,072,000 3,054,000 3,892,000 4,621,000 5,256,000 3,226,000 4,007,000  3,362,000 3,315,000 3,359,000 10,124,000 10,124,000 10,124,000 10,124,000 15,649,000 17,116,000 13,990,000 15,549,000 16,831,000 18,310,000 15,212,000 16,383,000 17,157,000 18,281,000 15,118,000     28,163,000 25,465,000 
        long–term debt
                                30,000,000 55,000,000 55,000,000 55,000,000 75,000,000 85,000,000 100,000,000 100,000,000 120,000,000  120,000,000                        
        restricted marketable securities, less current portion
                                128,335,000 155,571,000 159,321,000                                
        restricted cash and cash equivalents
                                   9,967,000  7,629,000 9,864,000 6,397,000 9,783,000                          
        marketable securities
                                   140,223,000    139,085,000 143,763,000                        68,401,000 53,660,000 
        restricted marketable securities
                                   18,676,000  144,885,000 144,689,000 21,012,000 15,627,000                        1,808,000  
        investments in limited liability companies
                                   32,362,000 30,073,000 28,014,000 27,499,000 36,339,000 35,431,000                          
        capital lease obligations, current portion
                                   3,924,000 3,865,000 3,808,000 3,751,000 3,696,000 3,641,000                          
        capital lease obligations, less current portion
                                   19,128,000 20,132,000 21,120,000 22,094,000 23,052,000 23,997,000  26,748,000 30,228,000 33,508,000                      
        restricted marketable debt securities
                                     20,064,000 18,067,000                            
        accounts receivables
                                       86,767,000 80,258,000                         51,260,000 
        stockholders’ equity:
                                                                  
        total stockholders' equity
                                        691,489,000     659,672,000 659,672,000 659,672,000 659,672,000                  
        total liabilities and stockholders’ equity
                                        1,110,837,000                         410,625,000 
        stockholders' equity:
                                                                  
        total liabilities and stockholders' equity
                                             922,447,000 922,447,000 920,181,000 920,181,000                  
        deferred tax asset
                                               10,564,000 10,564,000                  
        future service obligation
                                                                  
        deferred lease credits
                                                 606,000 909,000 1,212,000 1,515,000 1,817,000 2,120,000 2,423,000 2,726,000 3,029,000 3,332,000 3,635,000       
        commitments, contingencies and guarantees
                                                                  
        december 31
                                                   2,010,000    2,009,000    2,008,000      2,005,000 
        long-term debt, less current portion
                                                   10,000,000   10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000      13,568,000 
        revenues:
                                                                  
        net patient revenues
                                                            146,521,000 143,163,000 143,965,000    
        other revenues
                                                            16,750,000 17,399,000 16,176,000    
        costs and expenses:
                                                                  
        salaries, wages and benefits
                                                            88,036,000 86,312,000 87,541,000    
        other operating
                                                            44,755,000 44,639,000 45,314,000    
        recovery of notes receivable
                                                                  
        gain on sale of assets
                                                                  
        rent
                                                            7,834,000 7,876,000 7,918,000    
        depreciation and amortization
                                                            6,218,000 6,024,000 5,997,000    
        interest
                                                            274,000 170,000 219,000    
        income before income taxes
                                                            16,154,000 15,541,000 13,152,000    
        income tax provision
                                                            -2,381,000 -6,055,000 -4,980,000    
        net income
                                                            13,773,000 9,486,000 8,172,000 48,671,000   
        dividends to preferred shareholders
                                                            -2,169,000 2,168,000 2,168,000 -8,672,000   
        net income available to common shareholders
                                                            11,604,000 7,318,000 6,004,000 39,999,000   
        earnings per common share:
                                                                  
        basic
                                                            910 570 470 3,180   
        diluted
                                                            880 560 460 3,080   
        weighted-average common shares outstanding:
                                                                  
        revolving credit facility
                                                                  
        net operating revenues
                                                               581,483,000   
        earnings per share:
                                                                  
        restricted cash
                                                                101,564,000 87,771,000 
        doubtful accounts of 6,023 and 4,873, respectively
                                                                60,971,000  
        inventory at lower of cost (first–in,
                                                                  
        first–out method) or market
                                                                6,468,000  
        less accumulated depreciation and amortization
                                                                -134,555,000  
        net property and equipment:
                                                                127,225,000  
        bond reserve funds, mortgage replacement reserves
                                                                  
        and other deposits
                                                                108,000  
        unamortized financing costs
                                                                22,000 74,000 
        notes receivable from national
                                                                9,983,000 10,992,000 
        minority equity investments and other
                                                                7,529,000 1,280,000 
        the accompanying notes to interim condensed consolidated financial statements are an integral part
                                                                  
        of these consolidated balance sheets.
                                                                  
        the interim condensed consolidated balance sheet at december 31, 2006 is taken from the audited
                                                                  
        financial statements at that date.
                                                                  
        national healthcare corporation
                                                                  
        interim condensed consolidated balance sheets
                                                                  
        liabilities and shareholders= equity
                                                                  
        current portion of long–term debt
                                                                2,094,000  
        amounts due to third–party payors
                                                                11,564,000  
        accrued risk reserves
                                                                80,058,000 70,290,000 
        accrued interest
                                                                224,000 278,000 
        long–term debt, less current portion
                                                                10,000,000  
        deferred lease credit
                                                                5,755,000 6,154,000 
        shareholders= equity:
                                                                  
        preferred stock, .01 par value...
                                                                  
        authorized; none issued or outstanding
                                                                  
        authorized; 12,528,227 and 12,275,693 shares,
                                                                  
        respectively, issued and outstanding
                                                                125,000  
        retained earnings (the march 31, 2007 amount includes an
                                                                135,366,000  
        increase of 900 for the cumulative effect of
                                                                  
        implementing fin 48. see note 3)
                                                                  
        unrealized gains on marketable securities
                                                                24,151,000 17,044,000 
        total shareholders= equity
                                                                254,077,000  
        total liabilities and shareholders’ equity
                                                                487,297,000  
        tax refund receivable
                                                                  
        bond reserve funds, mortgage replacement reserves and other deposits
                                                                 57,000 
        current portion of long-term debt
                                                                 2,461,000 
        debt serviced by other parties, less current portion
                                                                  
        minority interests in consolidated subsidiaries
                                                                 1,185,000 
        total stockholders’ equity
                                                                 203,059,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 
                                                                                     
          cash flows from operating activities:
                                                                                     
          net income
        36,103,000 25,194,000 41,009,000 24,113,000 32,290,000 6,029,000 42,700,000 27,106,000 26,251,000 27,965,000 10,121,000 15,917,000 11,285,000 5,574,000 -3,107,000 2,161,000 15,349,000 15,995,000 -3,546,000 105,330,000 21,308,000 27,416,000 12,868,000 28,522,000 -26,816,000 13,687,000 19,376,000 13,682,000 21,231,000 18,136,000 21,087,000 22,375,000 -2,899,000 21,296,000 11,184,000 10,569,000 12,633,000 13,863,000 11,110,000 11,866,000 13,699,000 14,976,000 12,567,000 12,358,000 13,242,000 14,800,000 12,829,000 12,511,000 13,229,000 16,589,000 19,877,000 14,342,000 13,805,000 14,434,000 17,233,000 13,614,000 12,676,000 14,526,000 17,211,000 13,611,000 18,724,000 15,355,000 15,083,000 11,850,000 10,407,000 7,154,000 12,344,000 11,367,000 9,184,000 4,940,000 13,773,000 9,486,000 8,172,000 13,391,000 13,126,000 11,892,000 7,040,000 
          adjustments to reconcile net income to net cash from operating activities:
                                                                                     
          depreciation and amortization
        11,614,000 11,769,000 11,158,000 11,015,000 10,978,000 11,442,000 10,619,000 9,338,000 10,586,000 11,768,000 10,135,000 10,083,000 10,048,000 10,478,000 10,253,000 10,001,000 9,757,000 10,151,000 10,229,000 10,131,000 10,161,000 10,487,000 10,548,000 10,545,000 10,438,000 10,904,000 10,663,000 10,335,000 10,517,000 10,718,000 10,437,000 10,397,000 10,342,000 11,043,000 10,833,000                                           
          equity in losses of unconsolidated investments
        346,000                          -2,747,000 -2,480,000 -2,321,000  -2,724,000 -2,002,000 6,586,000                                             
          unrealized gains on marketable equity securities
        -9,074,000 4,404,000 -20,827,000 5,061,000 -10,982,000  -32,767,000 -9,124,000 -14,399,000    -1,386,000    -3,126,000         3,866,000                                                    
          gains on sale of marketable securities
        -173,000    -241,000                                                                         
          deferred income taxes
        2,725,000 3,877,000 4,006,000 -2,762,000 1,356,000 2,382,000 9,518,000 3,557,000 2,484,000 6,827,000 -2,256,000 866,000 331,000 1,018,000 1,011,000 1,366,000 2,600,000 -866,000 -5,288,000 -1,736,000 1,596,000 -188,000 1,124,000 3,479,000 -15,008,000 -2,135,000 4,893,000 -309,000 1,603,000 -349,000 3,443,000 2,830,000 -5,206,000 -5,595,000 2,421,000                                        4,063,000 -6,000 -12,804,000 
          stock–based compensation
        1,280,000 900,000 1,239,000 1,233,000 1,027,000 1,098,000 1,093,000 1,176,000 793,000 663,000 708,000 772,000 639,000 632,000 639,000 629,000 712,000 715,000 726,000 683,000 496,000 646,000 518,000 823,000 466,000 430,000 340,000 684,000 424,000 240,000 361,000 749,000 428,000 415,000 431,000                                          305,000 
          changes in operating assets and liabilities:
                                                                                     
          accounts receivable
        1,260,000 -6,554,000 9,613,000 -320,000 -6,416,000 -6,543,000 -19,056,000 16,277,000 -17,119,000 -5,942,000 -1,343,000 1,874,000 -3,148,000 -983,000 1,412,000 1,333,000 -5,624,000 2,895,000 -1,207,000 7,024,000 -4,622,000 -5,075,000 1,254,000 14,562,000 -6,212,000 -935,000 5,408,000 3,171,000 -3,345,000 -10,011,000 -3,924,000 2,776,000 1,761,000 -6,153,000 -2,435,000                                        -5,847,000   
          inventories
        -1,355,000 49,000 48,000 187,000 960,000 -1,197,000 -156,000 131,000 623,000 -13,000 -378,000 -49,000 142,000 210,000 65,000 1,223,000 -4,000 114,000 -757,000 178,000 664,000 -1,593,000 12,000 704,000 -372,000 333,000 -457,000 -364,000 517,000 120,000 -284,000 -40,000 -113,000 -40,000 85,000                                           
          prepaid expenses and other assets
        -1,335,000 1,992,000 2,605,000 -468,000 445,000 -2,526,000 4,320,000 1,336,000 3,153,000 -3,113,000 2,457,000 -1,970,000 1,957,000 373,000 -4,548,000 -2,551,000 -4,385,000 -1,613,000 593,000 -1,677,000 -601,000 1,735,000 755,000 3,752,000 -1,515,000 -456,000 759,000 418,000 -1,008,000 -407,000 215,000 -920,000 -631,000 146,000 27,000                                        183,000 -59,000 -1,194,000 
          operating lease obligations
        233,000 171,000 173,000 176,000 175,000 80,000 73,000 65,000 55,000 -308,000 -313,000 -307,000 -316,000                                                                 
          trade accounts payable
        -1,396,000 200,000 1,288,000 -367,000 -3,847,000 2,769,000 942,000 1,085,000 1,503,000 2,723,000 1,951,000 1,580,000 -4,018,000 -2,485,000 -6,697,000 298,000 3,354,000 -10,412,000 10,654,000 2,674,000 -4,999,000 1,222,000 1,448,000 167,000 -1,408,000 210,000 2,956,000 -3,581,000 -441,000 148,000 3,131,000 -549,000 737,000 1,242,000 -3,853,145                                          -783,000 
          accrued payroll
        5,658,000 -6,074,000 -1,653,000 15,384,000 3,541,000 2,962,000 3,862,000 18,081,000 -19,954,000 14,391,000 2,390,000 10,619,000 -15,800,000 -4,832,000 -8,319,000 11,784,000 -32,821,000 20,772,000 -7,338,000 25,635,000 -21,777,000 25,493,000 -520,000 12,318,000 -21,343,000 10,329,000 2,806,000 10,803,000 -21,730,000 9,131,000 2,799,000 11,205,000 -22,619,000 11,516,000 2,275,000                                        10,228,000 3,195,000 -5,522,000 
          amounts due to third party payors
        323,000 -1,321,000 -100,000 1,263,000 -1,454,000 -3,464,000 597,000 -1,770,000 1,619,000 2,781,000 -71,000 -1,020,000 48,000 1,135,000 -2,523,000 700,000 -276,000 549,000 115,000 865,000 -880,000 812,000 -2,182,000 2,217,000 353,000 -803,000 -888,000 506,000 185,000 -1,488,000 378,000 63,000 -234,000 -3,260,000 2,699,000                                        1,875,000 -1,296,000 -216,000 
          accrued risk reserves
        4,905,000 7,563,000 5,050,000 785,000 4,581,000 -6,588,000 950,000 1,017,000 4,978,000 -4,866,000 1,905,000 594,000 3,157,000 -1,241,000 1,047,000 1,250,000 3,365,000 -5,776,000 1,974,000 368,000 1,945,000 -6,523,000 1,117,000 4,237,000 4,623,000 -1,701,000 1,014,000 -1,271,000 2,498,000 150,000 1,130,000 -1,433,000 2,971,000 -1,305,000                                            
          other current liabilities
        7,238,000 -25,650,000 13,121,000 11,210,000 5,919,000 -15,783,000 11,134,000 -11,000 1,311,000 -8,659,000 4,249,000 4,379,000 5,407,000 -6,458,000 3,723,000 -1,410,000 1,701,000 -3,490,000 3,910,000 -6,131,000 4,331,000 -2,086,000 -3,995,000 8,614,000 3,365,000 -7,565,000 4,264,000 -4,077,000 8,158,000 -2,312,000 1,648,000 496,000 -1,882,000 -4,099,000                                            
          other noncurrent liabilities
        4,181,000 288,000 -245,000 154,000 923,000 -2,442,000 297,000 -9,858,000 1,530,000 -243,000 -201,000 316,000 6,554,000 4,679,000 -2,171,000 -512,000 1,386,000 -9,932,000 -2,833,000 -695,000 1,598,000 -4,299,000 3,606,000 9,307,000 -1,468,000 2,293,000 -1,630,000 89,000 102,000 501,000 -1,632,000 203,000 337,000 253,000 -1,808,000                                        -12,000 -2,252,000 11,574,000 
          net cash from operating activities
        62,533,000 16,807,000 66,197,000 62,819,000 39,255,000 12,789,000 34,207,000 50,661,000 9,646,000 25,733,000 32,305,000 39,321,000 13,857,000   26,242,000 -27,457,000 15,523,000 6,749,000 27,533,000 12,589,000 19,359,000 29,173,000 146,973,000 7,754,000 25,219,000 35,712,000 27,571,000 11,601,000 21,369,000 27,693,000 36,067,000 13,306,000 23,471,000 30,690,000                                        13,270,000 14,256,000 7,258,000 
          capital expenditures
        -9,640,000 -10,397,000 -9,708,000 -10,204,000 -6,137,000 -8,156,000 -5,656,000 -7,833,000 -5,955,000 -8,601,000 -6,511,000 -6,149,000 -6,640,000   -8,071,000 -8,962,000 -13,625,000 -12,631,000 -8,816,000 -4,327,000 -4,156,000 -5,200,000 -6,628,000 -6,730,000 -5,681,000 -8,115,000 -5,874,000 -7,064,000 -7,252,000 -8,356,000 -7,100,000 -8,019,000 -7,647,000                                        -3,399,000 -3,608,000 -4,814,000 
          free cash flows
        52,893,000 6,410,000 56,489,000 52,615,000 33,118,000 4,633,000 28,551,000 42,828,000 3,691,000 17,132,000 25,794,000 33,172,000 7,217,000   18,171,000 -36,419,000 1,898,000 -5,882,000 18,717,000 8,262,000 15,203,000 23,973,000 146,973,000 1,126,000 18,489,000 30,031,000 19,456,000 5,727,000 14,305,000 20,441,000 27,711,000 6,206,000 15,452,000 23,043,000                                        9,871,000 10,648,000 2,444,000 
          cash flows from investing activities:
                                                                                     
          purchases of property and equipment
        -9,640,000 -10,397,000 -9,708,000 -10,204,000 -6,137,000 -8,156,000 -5,656,000 -7,833,000 -5,955,000 -8,601,000 -6,511,000 -6,149,000 -6,640,000 -5,637,000 -7,530,000 -8,071,000 -8,962,000 -13,625,000 -12,631,000 -8,816,000 -4,327,000 -4,156,000 -5,200,000                                                       
          investments in unconsolidated companies
        -3,594,000 -2,506,000 82,000 -786,000 -2,419,000 -5,928,000 -3,514,000 -3,368,000 -1,488,000            -120,000 -60,000 -125,000   -231,000 -125,000     -70,000                                           
          collections of notes receivable
            7,000    16,000    2,000 -302,000 3,728,000 229,000 224,000 220,000 215,000 8,150,000 255,000 911,000 433,000 763,000 376,000 369,000 350,000 307,000 353,000 373,000 380,000 369,000 431,000 312,000 319,000                                          6,447,000 
          purchases of marketable securities
        -10,938,000 -8,235,000 -9,677,000 -36,214,000 -11,062,000 -10,321,000 -5,838,000 -10,195,000 -8,703,000 -7,738,000 -7,357,000 -4,125,000 -10,281,000 -5,076,000 -3,820,000 -10,769,000 -14,128,000   -35,617,000 -7,866,000                                                         
          proceeds from sale of marketable securities
        10,284,000  21,234,000 31,167,000 12,288,000  5,114,000 23,047,000 11,615,000  8,527,000 12,559,000 15,492,000  7,300,000 13,868,000 16,946,000   38,853,000 6,086,000                                                         
          net cash from investing activities
        -13,888,000 -12,934,000 1,978,000 -15,579,000 -7,323,000 -11,645,000 -224,058,000 1,425,000 -2,415,000 -10,186,000 -5,135,000 -820,000 -1,427,000 2,832,000 -647,000 -2,243,000 -5,920,000 -13,052,000 -20,842,000 -26,143,000 -5,852,000 -48,605,000 3,294,000 -2,342,000 -16,225,000 -4,442,000 1,547,000 -8,423,000 -2,947,000 -6,572,000 -10,288,000 -10,974,000 -5,828,000 -10,750,000 -7,585,000                                        -2,402,000 -1,267,000 1,751,000 
          cash flows from financing activities:
                                                                                     
          repayments under credit facility
        -40,000,000 -33,125,000 -36,875,000 -24,000,000 -3,000,000 -10,000,000                                                                       
          dividends paid to common stockholders
        -9,941,000 -9,931,000 -9,919,000 -9,434,000 -9,420,000 -9,419,000 -9,408,000 -9,086,000 -9,051,000 -9,040,000 -9,039,000 -8,733,000 -8,748,000 -8,774,000 -8,828,000 -8,509,000 -8,493,000 -8,020,000 -8,020,000 -8,002,000 -7,988,000 -7,986,000 -7,987,000 -7,980,000 -7,968,000 -7,968,000 -7,965,000 -7,652,000 -7,623,000 -7,613,000 -7,612,000 -7,305,000 -7,297,000 -7,294,000 -7,294,000                                           
          issuance of common stock
        12,268,000    1,278,000    8,412,000                                                                     
          repurchase of common shares
        -16,321,000 -5,164,000 -3,182,000 -4,662,000 -1,722,000 -2,100,000 -1,502,000 -9,900,000 -2,482,000 -2,996,000 -6,761,000 -146,000 -558,000 -278,000 -53,000 -872,000 -867,000                                             
          noncontrolling interest distributions
        -324,000                                                                             
          entrance fee deposits
        -186,000 51,000 20,000 -127,000 171,000                                                                      -230,000 392,000 -217,000 
          net cash from financing activities
        -54,504,000 -43,220,000 -47,003,000 -33,039,000 -12,693,000 -19,296,000 139,320,000 -7,613,000 -12,067,000 -9,834,000 -9,820,000 -10,272,000 -12,619,000 -12,101,000 -16,744,000 -8,347,000 -10,450,000 -9,495,000 -9,727,000 -6,894,000 -9,148,000 -8,370,000 -7,128,000 -58,032,000 31,641,000 -27,849,000 -35,083,000 -7,941,000 -8,875,000 -27,610,000 -18,543,000 -22,962,000 -8,159,000 -27,040,000                                         -3,223,000 -2,533,000 -2,441,000 
          net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents
        -5,859,000 -39,347,000 21,172,000 14,201,000 19,239,000 -18,152,000 -50,531,000   5,713,000 17,350,000       -7,024,000 -23,820,000 -5,504,000 -2,411,000 -37,616,000 25,339,000 86,599,000 23,170,000 -7,072,000 2,176,000    -1,138,000 2,131,000 -681,000   2,787,000 32,220,000                                         
          cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period
        112,187,000 96,922,000 125,968,000 74,865,000 119,743,000 158,502,000 61,010,000 54,920,000 67,421,000 31,589,000                                         
          cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period
        106,328,000 -39,347,000 21,172,000 14,201,000 116,161,000 -18,152,000 -50,531,000 44,473,000 121,132,000 5,713,000 17,350,000 28,229,000 74,676,000 2,665,000 -19,368,000 15,652,000 75,916,000 -7,024,000 -23,820,000 -5,504,000 156,091,000 -37,616,000 25,339,000 86,599,000 84,180,000 -7,072,000 2,176,000 11,207,000 54,699,000 -12,813,000 -1,138,000 2,131,000 66,740,000 -14,319,000 15,144,000 2,787,000 63,809,000                                         
          balance sheet classifications:
                                                                                     
          cash and cash equivalents
        85,526,000 -37,800,000 19,637,000 20,606,000 90,386,000 -8,686,000 -51,407,000 42,232,000 93,982,000 6,768,000 21,816,000 32,348,000 46,144,000 14,152,000 -31,283,000 18,805,000 56,993,000 -4,855,000 -22,230,000 585,000 134,107,000 -36,672,000 34,294,000 79,979,000 69,492,000 -8,927,000 29,515,000 -8,448,000 38,194,000 -12,352,000 -3,723,000 4,360,000 54,962,000 -10,672,000 8,942,000 13,752,000 47,096,000                                         
          restricted cash and cash equivalents
        20,802,000 -1,547,000 1,535,000 -6,405,000 25,775,000 -9,466,000 876,000 2,241,000 27,150,000 -1,055,000 -4,466,000 -4,119,000 28,532,000 -11,487,000 11,915,000 -3,153,000 18,923,000 -2,169,000 -1,590,000 -6,089,000 21,984,000 -944,000 -8,955,000 6,620,000 14,688,000 1,855,000 -27,339,000 19,655,000 16,505,000 -461,000 2,585,000 -2,229,000 11,778,000 -3,647,000 6,202,000 -10,965,000 16,713,000                                         
          total cash, cash equivalents, restricted cash, and restricted cash equivalents
        106,328,000 -39,347,000 21,172,000 14,201,000 116,161,000 -18,152,000 -50,531,000 44,473,000 121,132,000 5,713,000 17,350,000 28,229,000 74,676,000 2,665,000 -19,368,000 15,652,000 75,916,000 -7,024,000 -23,820,000 -5,504,000 156,091,000 -37,616,000 25,339,000 86,599,000 84,180,000 -7,072,000 2,176,000 11,207,000 54,699,000 -12,813,000 -1,138,000 2,131,000 66,740,000 -14,319,000 15,144,000 2,787,000 63,809,000                                         
          equity in earnings of unconsolidated investments
         294,000 104,000   62,000 -584,000 -67,000 -74,000 -185,000 -221,000 -1,535,000 21,000 -34,000 -10,000 -454,000 209,000 -14,000 -2,395,000 -2,911,000 -3,894,000 -3,019,000 -2,618,000 -2,811,000         -1,024,000 -2,528,000                                        -1,734,000 -1,422,000 -1,175,000 
          distributions from unconsolidated investments
             1,000     417,000 5,897,000 3,149,000 4,552,000 2,349,000 18,000 1,275,000 2,578,000 31,000 1,411,000 89,000 1,487,000 2,254,000 81,000 3,411,000                                        311,000 1,781,000 118,000 
          losses on sale of marketable securities
                -344,000    492,000 570,000 392,000                                                               
          gain on sale of unconsolidated company
             -1,024,000                                                                     
          gain on sale of property and equipment
                                                                                   
          acquisition of white oak manor, net of cash acquired
                                                                                     
          sale of marketable securities
                                                                                    
          collections of (investments in) notes receivable
         47,000                                                                           
          acquisition of other businesses, net of cash acquired
                                                                                    
          proceeds from sale of assets
                                                                                     
          borrowings under credit facility
                            40,000,000                                                     
          issuance of common shares
         4,799,000 2,953,000   797,000 2,232,000   53,000 254,000   833,000 161,000   1,036,000 2,078,000 327,000 681,000 126,000 549,000 400,000 963,000 804,000 579,000 1,538,000 260,000 1,067,000 897,000 131,000                                        5,000 177,000 317,000 
          noncontrolling interest contributions
             -274,000        250,000                                                             
          debt issuance costs
                                                                                     
          principal payments under finance lease obligations
             -860,000 -1,274,000 -1,256,000 -1,237,000 -1,218,000 -1,200,000 -1,183,000 -1,165,000 -1,147,000 -1,131,000 -1,114,000 -1,097,000 -1,081,000 -1,065,000 -1,049,000 -1,033,000 -1,019,000 -1,003,000 -988,000 -973,000 -959,000                                                 
          realized gains on sale of marketable securities
          -392,000                                                                           
          acquisition of white oak senior living, net of cash acquired
                                                                                     
          proceeds from the sale of unconsolidated company
                                                                                    
          contract liabilities
                7,667,000     -138,000 -448,000 -4,417,000 -10,019,000 -11,991,000 -13,108,000   261,000                                                       
          proceeds from sale of unconsolidated company
                2,100,000                                                                     
          unrealized losses on marketable equity securities
                 -12,001,000 3,093,000   4,327,000 11,056,000   -9,364,000 23,797,000 6,489,000 -7,059,000 -16,614,000 241,000 -20,053,000 60,392,000   54,000 -6,838,000                                                 
          impairment (recovery) of assets
                                                                                     
          provider relief funds
                     -516,000 -8,927,000 9,443,000 -10,429,000 -13,081,000 7,442,000 -5,336,000 2,110,000                                                       
          (investments in) collections of notes receivable
                                                                                     
          realized losses on sale of marketable securities
              19,000    42,000                                                                   
          investments in notes receivable
              135,000               -175,000 -250,000 -150,000 -5,000,000 -312,000                                                 
          entrance fee refunds
              207,000 148,000 -668,000  221,000 -308,000 -171,000  -133,000 207,000 -914,000    -128,000     61,000 -581,000    -159,000  -340,000                                           
          acquisition of skilled nursing facility
                                                                                   
          net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents
                -4,836,000    -189,000  -19,368,000 15,652,000 -43,827,000            -221,000                                                 
          gain on acquisition of equity method investment
                                -1,707,000                                                   
          proceeds from the sale of property and equipment
                                                                                    
          acquisition of equity method investment
                                                                                   
          recovery of notes receivable
                                                                                     
          investments in notes receivable
                                                                                     
          (investments in)/collections of notes receivable
                                                                                     
          gains on acquisition of equity method investments
                                                                                     
          acquisition of equity method investments
                                                                                     
          principal payments under credit facility
                                                                                     
          net cash from operating activities
                                                                                     
          acquisition of equity method investment, net of cash acquired
                              -6,648,000                                                    
          investments in unconsolidated companies and notes receivable
                                                                                     
          proceeds from sale of real estate
                                                                                     
          gains on sale of marketable securities
                        -45,000                                                             
          gains on acquisitions of equity method investments
                                                                                  
          gain on sale of skilled nursing facility
                                                                                     
          impairment of assets
                                                                                     
          federal income tax receivable
                                                                                     
          proceeds from the sale of skilled nursing facility
                                                                                     
          acquisitions of equity method investments
                                                                                     
          gains on sales of marketable securities
                                                                                     
          acquisitions of equity method investments, net of cash acquired
                                                                                    
          purchases of marketable securities
                                                                                     
          proceeds from sale of marketable securities
                                                                                     
          entrance fee (refunds) deposits
                          -593,000                                                           
          gains on sale of marketable debt securities
                                                                                     
          gains on sale of restricted marketable debt securities
                              -122,000 -11,000 -2,000 -10,000                                                    
          income tax receivable
                                2,560,000      -2,203,000 1,527,000 3,938,000  -3,466,000                                           
          purchases of restricted marketable debt securities
                                -1,284,000                                                    
          proceeds from sale of restricted marketable debt securities
                              8,181,000                                                       
          noncontrolling interest contributions/
                              1,963,000                                                       
          entrance fee deposits/
                              -181,000                                                       
          deferred revenue
                                1,870,000 -683,000 -561,000 -692,000 2,018,000 -838,000 -729,000 -635,000 2,030,000 -781,000 -879,000                                           
          additions to property and equipment
                                -6,628,000 -6,730,000 -5,681,000 -8,115,000 -5,874,000 -7,064,000 -7,252,000 -8,356,000 -7,100,000 -8,019,000 -7,647,000                                           
          purchase of restricted marketable debt securities
                                -6,360,000   -3,322,000 -3,565,000                                                 
          sale of restricted marketable debt securities
                                3,410,000   23,527,000 6,576,000                                                 
          equity contributed by noncontrolling entities
                                281,000                                                     
          obligation to provide future services
                                                                                     
          principal payments under line of credit agreement
                                                                                     
          distributions attributable to noncontrolling interest
                                 98,000 -549,000                                                   
          equity contributed by noncontrolling interest
                                                                                     
          (investments in)/distributions from unconsolidated investments
                                                                                     
          sales of restricted marketable debt securities
                                                                                     
          principal payments on debt
                                      -10,000,000                                               
          unrealized gains on marketable securities
                                                                                     
          principal payments under capital lease obligations
                                     -945,000 -931,000 -917,000 -903,000 -890,000 -876,000                                           
          equity attributable to noncontrolling interest
                                         247,000                                           
          tax expense from exercise of stock options
                                                                                     
          change in deposits
                                                                                     
          net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents
                                         -14,319,000                                            
          distributions from/(investments in) unconsolidated companies
                                                                                     
          purchase of restricted marketable securities
                                      -3,405,000 -3,851,000 -2,694,000                                             
          sale of restricted marketable securities
                                      140,000 864,000 3,535,000                                             
          gains on sale of restricted marketable securities
                                       -14,000 -11,000  -17,000                                           
          unrealized losses on marketable securities
                                        15,517,000                                             
          provision for doubtful accounts
                                                                                     
          redemption of preferred shareholders
                                                                                     
          dividends paid to preferred stockholders
                                                                                     
          tax benefit from exercise of stock options
                                                                                  133,000 62,000 
          provision for doubtful accounts receivable
                                          1,817,000                                        49,000 429,000 388,000 
          changes in operating assets and liabilities, net of the effect of acquisitions:
                                                                                     
          purchases of restricted marketable securities
                                                                                     
          sales of restricted marketable securities
                                                                                     
          tax expense from stock–based compensation
                                                                                     
          adjustments to reconcile net income to net cash provided by operating activities:
                                                                                     
          other current liabilities and accrued risk reserves
                                                                                    6,871,000 
          net cash used in financing activities
                                                                                     
          net increase in cash and cash equivalents
                                              -18,331,000 -11,640,000 10,975,000 -32,573,000 -719,000 -6,711,000 8,444,000 -7,150,000 1,159,000 -8,379,000 2,432,000 -6,705,000 13,776,000 795,000 7,138,000 -17,006,000 14,498,000 9,495,000 -1,294,000 7,850,000 15,827,000 3,827,000 5,026,000 -390,000 6,305,000 -5,226,000 -11,233,000 -36,097,000 10,583,000 3,918,000 11,585,000 -724,000 19,966,000 12,503,000 14,909,000 -72,968,000 7,645,000 10,456,000 6,568,000 
          cash and cash equivalents, beginning of period
                                              38,208,000 69,767,000 81,705,000 66,701,000 61,008,000 28,478,000 39,022,000 49,033,000 2,379,000 50,678,000 
          cash and cash equivalents, end of period
                                              -18,331,000 -11,640,000 49,183,000 -32,573,000 -719,000 -6,711,000 78,211,000 -7,150,000 1,159,000 -8,379,000 84,137,000 -6,705,000 13,776,000 795,000 73,839,000 -17,006,000 14,498,000 9,495,000 59,714,000 7,850,000 15,827,000 3,827,000 33,504,000 -390,000 6,305,000 -5,226,000 27,789,000 -36,097,000 10,583,000 3,918,000 60,618,000 -724,000 19,966,000 12,503,000 17,288,000 -72,968,000 7,645,000 10,456,000 57,246,000 
          supplemental disclosure of non-cash investing and financing activities:
                                                                                     
          buildings, personal property, and obligations recorded under capital lease agreements
                                                      39,032,000                             
          adjustments to reconcile net income to net cash
                                                                                     
          depreciation
                                                                                  3,881,000 3,771,000 3,792,000 
          amortization of intangibles and deferred charges
                                                                                  10,000 11,000 10,000 
          gain on sale of land
                                                                                     
          amortization of deferred income
                                                                                  368,000 -468,000 -354,000 
          deferred income
                                                                                  -932,000 -870,000 2,669,000 
          decrease in restricted cash
                                                                                  2,369,000   
          stock based compensation
                                                                                  386,000   
          amortization of deferred lease credit
                                                                                     
          inventory
                                                                                  173,000 -8,000 -91,000 
          accounts payable
                                                                                  580,000   
          accrued interest
                                                                                    205,000 
          other current liabilities and accrued reserves
                                                                                  -3,563,000   
          additions to and acquisitions of property and equipment
                                                                                  -3,399,000 -3,608,000 -4,814,000 
          collection of notes receivable
                                                                                  686,000   
          purchase of marketable securities
                                                                                     
          increase in minority interests in consolidated subsidiaries
                                                                                   1,000 -11,000 
          increase in bond reserve funds, mortgage replacement reserves
                                                                                     
          and other deposits
                                                                                  -30,000   
          dividends paid to shareholders
                                                                                  -2,633,000 -2,255,000 -2,248,000 
          payments on debt
                                                                                  -569,000 -563,000 -554,000 
          increase in restricted cash
                                                                                    -5,594,000 
          changes in assets and liabilities:
                                                                                     
          accounts (and other) receivables
                                                                                    2,354,000 
          increase in bond reserve funds and other deposits
                                                                                     
          supplemental information:
                                                                                     
          cash payments for interest
                                                                                    71,000 
          cash payments for income taxes
                                                                                    550,000 
          provided by operating activities:
                                                                                     
          write-off of notes receivable
                                                                                     
          realized gain on sale of marketable securities
                                                                                     
          stock compensation
                                                                                     
          tax refund receivable
                                                                                     
          disposals of property and equipment
                                                                                     
          collections of receivables from exercise of options
                                                                                     
          decrease in bond reserve funds, mortgage
                                                                                     
          replacement reserves and other deposits
                                                                                     
          purchase of common shares
                                                                                     
          decrease in bond reserve funds, mortgage replacement reserves and other deposits
                                                                                     
          increase in financing costs